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Abstract. 
 
The zinc finger protein A20 is a tumor necro-
sis factor (TNF)– and interleukin 1 (IL-1)-inducible 
protein that negatively regulates nuclear factor-kappa
 
 
 
B (NF-
 
k
 
B)–dependent gene expression. However, the 
molecular mechanism by which A20 exerts this effect is 
still unclear. We show that A20 does not inhibit TNF-
induced nuclear translocation and DNA binding of 
NF-
 
k
 
B, although it completely prevents the TNF-
induced activation of an NF-
 
k
 
B–dependent reporter 
gene, as well as TNF-induced IL-6 and granulocyte 
macrophage–colony stimulating factor gene expression. 
Moreover, NF-
 
k
 
B activation induced by overexpres-
sion of the TNF receptor–associated proteins TNF re-
ceptor–associated death domain protein (TRADD),
receptor interacting protein (RIP), and TNF recep-
tor–associated factor 2 (TRAF2) was also inhibited by 
expression of A20, whereas NF-
 
k
 
B activation induced 
by overexpression of NF-
 
k
 
B–inducing kinase (NIK) or 
the human T cell leukemia virus type 1 (HTLV-1) Tax 
was unaffected. These results demonstrate that A20 in-
hibits NF-
 
k
 
B–dependent gene expression by interfering 
with a novel TNF-induced and RIP- or TRAF2-medi-
ated pathway that is different from the NIK–I
 
k
 
B kinase 
pathway and that is specifically involved in the transac-
tivation of NF-
 
k
 
B. Via yeast two-hybrid screening, we 
found that A20 binds to a novel protein, ABIN, which 
mimics the NF-
 
k
 
B inhibiting effects of A20 upon over-
expression, suggesting that the effect of A20 is medi-
ated by its interaction with this NF-
 
k
 
B inhibiting pro-
tein, ABIN.
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 necrosis factor (TNF)
 
1
 
 is a pleiotropic cyto-
kine that acts as an important mediator of inflam-
mation and immune responses by modulating the
expression of many inflammatory proteins (Barnes and
Karin, 1997). Induction of specific transcriptional pro-
grams by TNF is mediated by the activation of the tran-
scription factor nuclear factor-kappa B (NF-
 
k
 
B). More-
over, an antiapoptotic function for NF-
 
k
 
B has been
described recently (for review see Van Antwerp et al.,
1998). TNF-induced activation of NF-
 
k
 
B is initiated by the
recruitment of a number of proteins to both TNF recep-
tors, with the TNF-R55 being far more effective than the
TNF-R75 (Vandenabeele et al., 1995). The TNF-R55 re-
cruits by its death domain the death domain—containing
adapter protein TRADD (TNF receptor—associated death
domain protein) (Hsu et al., 1995), which then interacts
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1. 
 
Abbreviations used in the paper:
 
 ABIN, A20 binding inhibitor of NF-
 
k
 
B
activation; CBP, CREB (cAMP responsive element binding protein)
binding protein; GFP, green fluorescent protein; GM-CSF, granulocyte
macrophage–colony stimulating factor; HTLV-1, human T cell leukemia
virus type 1; IKK, I
 
k
 
B kinase; IL, interleukin; MAP kinase, mitogen-acti-
vated protein kinase; NF-
 
k
 
B, nuclear factor-kappa B; NIK, NF-
 
k
 
B–induc-
ing kinase; RIP, receptor interacting protein; SRE, serum response ele-
ment; TNF, tumor necrosis factor; TPA, tetradecanoic phorbol acetate;
TRADD, TNF receptor–associated death domain protein; TRAF, TNF
receptor–associated factor.
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with the death domain—containing proteins FADD/MORT1
and receptor interacting protein (RIP) (Hsu et al., 1996a,b).
The former initiates signaling leading to apoptosis (Boldin
et al., 1996; Muzio et al., 1996), whereas the latter recently
has been shown to be crucial for NF-
 
k
 
B activation by TNF
(Kelliher et al., 1998). Moreover, TRADD can also recruit
the TNF receptor—associated factor 2 (TRAF2) via a di-
rect interaction or via the interaction of TRAF2 with RIP
(Hsu et al., 1996a). TRAF2 belongs to a larger family
whose members have been shown to be involved in NF-
 
k
 
B
activation by several members of the TNF receptor family,
including TNF-R55, TNF-R75, CD30, and CD40, but also
by the interleukin 1 (IL-1) receptor (Cao et al., 1996; Hsu
et al., 1996b; Ishida et al., 1996; Lee et al., 1996; Ng et al.,
1998).
Studies with TRAF2-deficient cells recently have sug-
gested that there is a lot of redundancy within the TRAF
family (Yeh et al., 1997). TRAFs are believed to provide
the signal to NF-
 
k
 
B activation by directly associating with
the NF-
 
k
 
B—inducing kinase (NIK) (Malinin et al., 1997).
NIK associates with and activates at least two kinases, I
 
k
 
B
kinase (IKK)
 
a
 
 and IKK
 
b
 
, which phosphorylate the inhibi-
tory subunit I
 
k
 
B leading to its degradation and the migra-
tion of NF-
 
k
 
B to the nucleus (Mercurio et al., 1997; Zandi
et al., 1997). In addition to the NIK—I
 
k
 
B pathway, TRAF2
also initiates the activation of JNK and p38 mitogen-acti-
vated protein (MAP) kinases, which also have been shown
to be important regulators of gene expression (Beyaert et
al., 1996; Reinhard et al., 1997; Carpentier et al., 1998).
Besides I
 
k
 
B, NF-
 
k
 
B—dependent gene expression is also
negatively regulated by the zinc finger protein A20 (Coo-
per et al., 1996; Jttel et al., 1996). The latter can be
induced by different stimuli including: TNF, bacterial
lipopolysaccharide, IL-1, tetradecanoic phorbol acetate
(TPA), activation of the B cell surface receptor CD40, ad-
hesion to extracellular matrix proteins, as well as over-
expression of the human T cell leukemia virus type I
(HTLV-1) Tax and the Epstein-Barr virus LMP1 gene
product (Dixit et al., 1990; Laherty et al., 1992, 1993; Yu-
rochko et al., 1992; Sarma et al., 1995). The expression of
A20 is itself under the control of NF-
 
k
 
B (Krikos et al.,
1992), suggesting that A20 is involved in the negative feed-
back regulation of NF-
 
k
 
B activation. However, the molec-
ular mechanism of A20-mediated inhibition of NF-
 
k
 
B ac-
tivation is at present unclear. Here we show that A20
inhibits TNF-induced NF-
 
k
 
B—dependent gene expression
by interfering with a TRAF2-mediated signaling pathway
that is different from the NIK—I
 
k
 
B or the p38 MAP kinase
pathway, and which is specifically involved in the transac-
tivation of NF-
 
k
 
B. Furthermore, we demonstrate that the
A20 binding inhibitor of NF-
 
k
 
B activation (ABIN), a pro-
tein that interacts with the functional COOH-terminal
part of A20, has similar NF-
 
k
 
B inhibiting effects as A20,
suggesting that A20 can inhibit NF-
 
k
 
B activation via its in-
teraction with ABIN.
 
Materials and Methods
 
Cloning of the mA20 Gene
 
L929r2 murine fibrosarcoma cells (Vanhaesebroeck et al., 1991) were
treated for 4 h with 1,000 IU/ml mTNF and 10 
 
m
 
g/ml cycloheximide.
Poly(A)
 
1
 
-mRNA was extracted and the first strand cDNA was synthe-
sized using random primers (De Valck et al., 1996). Transformed MC1061
bacteria, containing the L929r2 cDNA library, were grown or lifted on
C/P lift membranes (Bio-Rad Laboratories). The membranes were
soaked for 7 min in denaturing solution (1.5 M NaCl, 0.5 M NaOH), twice
for 3 min in neutralizing solution (1.5 M NaCl, 0.5 M Tris-HCl, pH 7.2,
1 mM EDTA) and washed in 2
 
3 
 
SSC. DNA was fixed on the membranes
by UV illumination and baking for 2 h at 80
 
8
 
C. The filters were incubated
in prehybridization solution (1 mM EDTA, 0.5 M NaHPO
 
4
 
, pH 7.2, 7%
SDS) at 60
 
8
 
C. Hybridization was done with the [
 
32
 
P]dCTP-labeled StuI-
XhoI fragment of hA20 cDNA. Filters were washed at room temperature
with a buffer containing 1 mM EDTA, 40 mM NaHPO
 
4
 
, pH 7.2, and 5%
SDS, and subjected to autoradiography. Nine individual clones giving a
positive signal were obtained. The plasmid of one of these clones con-
tained a cDNA insert of 
 
z
 
3.7 kb, including besides the complete coding
sequence of mA20 also part of the 5
 
9
 
 and 3
 
9
 
 untranslated region.
 
Reagents
 
Recombinant mTNF and hTNF were produced by 
 
Escherichia coli
 
 and
purified to at least 99% homogeneity. The preparations used had a spe-
cific biological activity of 1.4 
 
3
 
 10
 
8
 
 IU/mg and 8.8 
 
3
 
 10
 
6
 
 IU/mg purified
protein, respectively, as determined with the international standard (code
88/532 and code 87/650; National Institute for Biological Standards and
Control). Recombinant murine IL-1
 
b
 
 was produced by 
 
E. coli
 
 and puri-
fied to at least 99% homogeneity. The preparations used had a specific bi-
ological activity of 3.65 
 
3
 
 10
 
8
 
 IU/mg purified protein, as determined with
the international standard (code 93/668). TPA was purchased from Sigma
Chemical Co. Recombinant green fluorescent protein (rGFP) and poly-
clonal rabbit antiserum directed against rGFP originated from CLON-
TECH Laboratories and polyclonal phosphospecific p38 MAP kinase an-
tibody and polyclonal p38 MAP kinase antibody were purchased from
New England Biolabs.
 
Expression Plasmids
 
The cDNAs encoding mutant GFP (S65T) and a fusion protein of GFP
(S65T) followed by murine A20 were cloned in the eukaryotic expression
plasmid pCAGGS (Niwa et al., 1991). A20 was cloned as a blunted NcoI-
EcoRI fragment in the SmaI site of the multiple cloning site inserted be-
fore the stop codon of GFP (pCAGGS-GFP/A20). The eukaryotic ex-
pression plasmids for ABIN were made by inserting the corresponding
PCR fragment in frame with an NH
 
2
 
-terminal E-tag into pCAGGS. PCR
fragments encoding TRADD and RIP were cloned in the pCDNA1 vec-
tor in frame with a COOH-terminal E-tag. The PCR fragment encoding
CD40 was cloned in the plasmid pCDNA3 (pCDNA3-CD40) and was a
gift of Dr. S. Pype (Catholic University of Leuven, Leuven, Belgium). Ex-
pression plasmids encoding TRAF2 and NIK were gifts of Dr. D. Goeddel
(Tularik, San Francisco, CA) and Dr. D. Wallach (Weizmann Institute of
Science, Rehovot, Israel), respectively. The plasmids phIL6LUC and
p(
 
k
 
B)
 
3
 
LUC have been described previously (Plaisance et al., 1997). The
plasmid pNFconluc, encoding the luciferase reporter gene driven by a
minimal NF-
 
k
 
B responsive promoter was a gift of Dr. A. Israel (Institut
Pasteur, Paris, France). The plasmids pAP1-luc and pSRE-luc were ob-
tained from Stratagene. The plasmid pUT651, encoding 
 
b
 
-galactosidase,
was obtained from Eurogentec and the plasmid pIEX encoding the
HTLV-1 Tax under control of the CMV promoter was obtained from Dr.
K.-T. Jeang (National Institutes of Health, Bethesda, MD) (Semmes and
Jeang, 1992). An expression plasmid for p300 (pCMV-p300) was provided
by Dr. R. Eckner (Institute for Molecular Biology, Zurich, Switzerland)
(Eckner et al., 1994). The yeast plasmid pAS2-A20 was described earlier
(De Valck et al., 1996).
 
Cell Culture Conditions
 
L929sA and L929r2 murine fibrosarcoma cells and human embryonic kid-
ney cells 293T were grown as described (Vanhaesebroeck et al., 1991; De
Valck et al., 1997). Stable transfection of L929sA cells with the expression
vectors was carried out by the calcium phosphate–DNA precipitation
method. The pSV2neo-plasmid containing the neomycin resistance gene
was coprecipitated as a selection marker (Southern and Berg, 1982). Se-
lection of transfected clones was obtained by adding G418 (600 
 
m
 
g/ml) to
the growth medium of the cells. Cells were mycoplasma-free, as judged by
a DNA fluorochrome assay.
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IL-6 Assay and Granulocyte Macrophage Colony 
Stimulating Factor (GM-CSF) Assay
 
L929sA transfectants were seeded in a 6-well plate at 6 
 
3 
 
10
 
5
 
 cells/ 500 
 
m
 
l
medium/well. After 24 h, cells were either stimulated for 6 h with 1,000
IU/ml mTNF or left untreated. Supernatants were harvested and assayed
for IL-6 or GM-CSF in a 7TD1 or a FDCp1 cell proliferation assay, re-
spectively (DeLamarter et al., 1985; Van Snick et al., 1986).
 
NF-
 
k
 
B Gel Retardation Assay
 
Cells in a 6-well plate were stimulated with 1,000 IU/ml mTNF for 5, 15, or
30 min, and nuclear fractions were prepared as described by Dignam et al.
(1983). NF-
 
k
 
B DNA binding was analyzed by incubating 10 
 
m
 
g nuclear
proteins for 30 min with the NF-
 
k
 
B specific 
 
32
 
P-labeled oligonucleotide
probe (5
 
9
 
-agctATGTGGGATTTTCCCATGAGCagct-3
 
9
 
) containing the
NF-
 
k
 
B site from the promoter of the mIL-6 gene. Protein–DNA com-
plexes were separated on a 4% native polyacrylamide gel as described
previously (Beyaert et al., 1996).
 
Transient Transfections and Reporter Gene Assays
 
L929sA cells were seeded at a density of 2 
 
3 
 
10
 
6
 
 cells/75-cm
 
2
 
 flask. 24 h
later, cells were transfected by the DNA–calcium phosphate cotransfec-
tion method with the plasmids pUT651 and phIL6LUC or p(
 
k
 
B)
 
3
 
LUC.
The plasmids phIL6LUC and p(
 
k
 
B)
 
3
 
LUC contain the luciferase gene af-
ter the complete hIL-6 promoter or the minimal hIL-6 promoter preceded
by three copies of the NF-
 
k
 
B recognition site, respectively. 48 h after
transfection, cells were trypsinized and seeded at 1.2 
 
3 
 
10
 
5
 
 cells/24-well.
At 66 h after transfection, cells were either noninduced or induced for 6 h
with 1,000 IU/ml hTNF. Inducible promoter activity was determined by
measuring the luciferase and 
 
b
 
-galactosidase activity present in cell ex-
tracts as described previously (De Valck et al., 1996). Transfection of
293T cells proceeded similarly, except that 293T cells were plated in 6-well
plates at 4 
 
3 
 
10
 
5
 
 cells per well and transiently transfected with 800 ng ex-
pression plasmids as well as 100 ng of pNFconluc and 100 ng pUT651. For
measurements of AP1- and serum responsive element (SRE)–mediated
transcription, cells were transfected with 100 ng of the plasmids pAP1-luc
or pSRE-luc instead of 100 ng pNFconluc.
 
p38 MAP Kinase Phosphorylation Analysis
 
10
 
6
 
 L929sA cells were seeded in 6-well plates. The next day, cells were ei-
ther untreated or treated with 1,000 IU/ml mTNF for 5, 15, or 30 min. Cell
lysates were prepared by directly adding SDS sample buffer (62.5 mM
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT, 0.1% bromophe-
nol blue) to the cells. Proteins were separated by 15% SDS-PAGE and
blotted on a nitrocellulose filter. Phosphorylated p38 MAP kinase was
detected with a polyclonal phosphospecific p38 MAP kinase antibody
and enhanced chemiluminescence (Amersham International). The total
amount of p38 MAP kinase present in the same cell extracts was revealed
with a polyclonal p38 MAP kinase specific antibody.
 
Yeast-based Two-Hybrid Screening
 
The yeast two-hybrid system was purchased from CLONTECH Laborato-
ries. The screening of a L929r2 cDNA library with pAS2-A20 was de-
scribed previously (De Valck et al., 1997). Yeast colonies expressing inter-
acting proteins were selected by growth on minimal media lacking Trp,
Leu, and His, in the presence of 5 mM 3-amino-1,2,4-triazole and by
screening for 
 
b
 
-galactosidase activity. Plasmid DNA was extracted from
the positive colonies and the pGAD424 vectors encoding candidate A20-
interacting proteins were recovered by electroporation in the 
 
E. coli
 
 strain
HB101 and growth on media lacking Leu.
 
Cell Transfection, Coimmunoprecipitation, and 
Western Blotting
 
2 
 
3
 
 10
 
6 
 
human embryonic kidney 293T cells were plated on 10-cm petri
dishes and transiently transfected by calcium phosphate–DNA coprecipi-
tation. 24 h after transfection, cells were lysed in 500 
 
m
 
l of lysis buffer (50
mM Hepes, pH 7.6, 250 mM NaCl, 0.1% NP-40, 5 mM EDTA). Lysates
were incubated with 5 
 
m
 
l of rabbit anti-GFP antibody (CLONTECH
Laboratories) and immunocomplexes were immobilized on protein
A–Trisacryl (Pierce Chemical Co.). The latter were washed twice with ly-
 
sis buffer and twice with lysis buffer containing 1 M NaCl. Coprecipitating
proteins were separated by SDS-PAGE and analyzed by Western blotting
with mouse anti–E-tag antibody (Pharmacia Biotech).
 
Localization of GFP and GFP/A20 and 
Immunolocalization of ABIN
 
Localization of GFP/A20 was analyzed by means of GFP fluorescence.
Therefore, L929sA cells stably expressing GFP or GFP/A20 were seeded
on coverslips in 6-well plates and microscopically analyzed for GFP fluo-
rescence (emission at 510 nm) at an excitation wavelength of 485 nm.
To identify the subcellular localization of ABIN, 4 
 
3 
 
10
 
5 
 
293T cells
were seeded on coverslips in 6-well plates and transfected with 1 
 
m
 
g plas-
mid DNA. 24 h after transfection, cells were fixed on the coverslips with
3% paraformaldehyde. Upon permeabilization with 1% Triton X-100, the
cells were incubated for 2 h with mouse anti–E-tag antibody (1/1,000) fol-
lowed by a second incubation with anti-mouse Ig antibody coupled to bi-
otin (1/1,000; Amersham). After a subsequent incubation with streptavi-
din coupled to Texas red (Amersham), fluorescence can be analyzed via
fluorescence microscopy (Axiophot; Zeiss), using a filter set with excita-
tion at 543 nm and emission at 600 nm. In the same cells, fluorescence of
GFP can be detected at a different wavelength, namely excitation at 485
nm and emission at 510 nm.
 
Results
 
A20 Inhibits TNF-induced Expression of IL-6
GM-CSF, and an NF
 
-
 
k
 
B–dependent Reporter Gene
 
A20 has been described as a TNF inducible inhibitor of
NF-
 
k
 
B activation, mainly on the basis of its effect on NF-
 
k
 
B–dependent expression of a reporter gene (Cooper et
al., 1996; Jäättelä et al., 1996). Therefore, we first analyzed
its effect on the TNF-induced expression of IL-6 and GM-
CSF in control (L929SA-neo) and in L929sA cells over-
expressing either a fusion protein of A20 with GFP
(L929SA-GFP/A20) or GFP as such (L929SA-GFP). Ex-
pression of these cytokines has been shown to be NF-
 
k
 
B–
dependent (Schreck et al., 1990; Zhang et al., 1990). Com-
pared with the amount of IL-6 and GM-CSF found in the
supernatant of TNF-treated L929SA-neo and L929SA-
GFP cells, their levels were considerably decreased in
L929SA-GFP/A20 cells (Table I). A similar inhibitory ef-
fect of A20 on TNF-induced gene activation could be seen
when GFP-A20 expressing L929sA cells were transiently
transfected with an expression plasmid containing the lu-
ciferase reporter gene under control of either the hIL-6
promoter (phIL6LUC) or a minimal promoter with three
NF-
 
k
 
B–binding sites [p(
 
k
 
B)
 
3
 
LUC], and analyzed for lu-
ciferase expression upon stimulation with 1,000 IU/ml
mTNF for 6 h (partially shown in Fig. 1 A). These results
demonstrate that A20 interferes with the NF-kB–depen-
dent expression of a reporter gene as well as with the ex-
pression of endogenous genes that are NF-
 
k
 
B regulated.
 
A20 Does Not Prevent the Nuclear Translocation and 
DNA Binding of NF-kB
NF-kB activation involves the release of the inhibitory
protein IkB from NF-kB in the cytosol, leading to the nu-
clear translocation and binding of NF-kB to its specific
recognition sequence in DNA (Henkel et al., 1993). The
latter can be analyzed in a gel shift assay in which binding
of active NF-kB to an NF-kB specific DNA probe leads to
a slower migration of this probe in a nondenaturing poly-
acrylamide gel. Nuclear fractions prepared from L929SA-
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neo, L929SA-GFP, and L929SA-GFP/A20 cells that were
either unstimulated or stimulated for 30 min with mTNF
were analyzed in such an assay. Remarkably, although
A20 completely prevented NF-kB–dependent gene ex-
pression as described above, no clear differences in TNF-
induced DNA binding of NF-kB were observed (Fig.
1 B). Also, stimulation of these cells for shorter peri-
ods, 5 or 15 min, did not reveal an effect of A20 (data not
shown). Nevertheless, TNF-induced nuclear translocation
and DNA binding of NF-kB could be completely abol-
ished by pretreatment with the proteasome inhibitor
MG132 that inhibits NF-kB activation by preventing IkB
degradation (Chen et al., 1995; data not shown). These re-
sults indicate that A20 inhibits NF-kB–dependent gene in-
duction by specifically interfering with an NF-kB transac-
tivation signal, without affecting the nuclear translocation
and DNA binding of NF-kB.
By the presence of seven zinc finger structures in A20, it
has been originally suggested that A20 may bind to DNA
and directly interfere with the transcriptional machinery
(Opipari et al., 1990). However, more recently, it has been
demonstrated that A20 transiently expressed in 293T cells
exclusively localized in the cytoplasm (Vincenz and Dixit,
1996). In our L929sA cells stably expressing GFP/A20 fu-
sion proteins, a similar speckled cytoplasmic staining was
observed via GFP fluorescence and confocal microscopy
(Fig. 2). In contrast, GFP as such was detected both in the
cytoplasm and the nucleus. Furthermore, treatment of the
cells with TNF did not induce a detectable relocalization
of A20 (data not shown). These results suggest that A20
cannot directly interfere with NF-kB transcriptional activ-
ity, but indicate that A20-mediated inhibition of NF-kB
transactivation is a cytosolic event.
A20 Inhibits a TNF-induced NF-kB Transactivation 
Pathway That Is Initiated at the Level of RIP/TRAF2 
and That Is Independent of NIK
TNF-induced activation of NF-kB involves the recruit-
ment of several cytoplasmic signaling proteins to the TNF-
R55 (for review see Darnay and Aggarwal, 1997), which is
the main signaling receptor for TNF. Moreover, overex-
pression of some of these proteins is sufficient to induce
NF-kB activation. To investigate at which step A20 inter-
feres with NF-kB activation, we tested the effect of A20 on
NF-kB–dependent gene expression induced by TNF treat-
ment or by overexpression of the TNF receptor associat-
ing proteins TRADD, RIP, TRAF2, and NIK in 293T
cells. As expected, A20 completely prevented NF-kB–
dependent luciferase expression induced by TNF (Fig. 3).
A similar protective effect of A20 could be observed when
NF-kB was activated by overexpression of TRADD, RIP,
or TRAF2. However, NF-kB activation by overexpression
of downstream acting NIK was not sensitive to A20. These
results clearly demonstrate that A20 interferes with an
RIP- or TRAF2-initiated NF-kB transactivation signal,
which is different from the NIK-mediated pathway leading
to nuclear translocation of NF-kB.
Inhibition of NF-kB Activation by A20
Is Stimulus-dependent
Recently, it was shown that activation of NF-kB induced
by the HTLV transactivator Tax protein is mediated by
NIK and both IKKa and IKKb (Chu et al., 1998; Uhlik
et al., 1998; Yin et al., 1998). In contrast, overexpression
of a TRAF2 dominant negative mutant was not able to
block Tax-induced NF-kB activation, excluding a role for
TRAF2 in this pathway (Geleziunas et al., 1998; Yin et al.,
1998). Therefore, we tested the effect of GFP/A20 overex-
pression on Tax-induced expression of an NF-kB–depen-
dent reporter gene in 293T cells. Whereas TNF-induced
NF-kB activation was completely prevented by A20, the
latter could not block the gene-inducing effects mediated
Figure 1. A20 inhibits NF-kB—dependent promoter activity with-
out affecting NF-kB binding to DNA. (A) L929sA clones stably
expressing the neomycin resistance gene alone or in combination
with the plasmids encoding GFP or GFP/A20 as indicated were
transiently transfected with a luciferase reporter gene under the
control of three NF-kB recognition sequences [p(kB)3LUC].
Cells were either untreated (open bars) or treated with 1,000 IU/
ml mTNF (filled bars) for 6 h. Promoter activity is expressed as
the luciferase (luc) activity relative to the b-galactosidase (gal)
activity in order to correct for differences in transfection effi-
ciency. Data from a representative experiment (total number of
experiments, 2) are expressed as the mean value (n 5 3) with
SD , 10%. (B) The same transfectants were either untreated
(2) or treated with 1,000 IU/ml mTNF (1) for 30 min. Nuclear
extracts were analyzed for active NF-kB in an electrophoretic
mobility shift assay as described in Materials and Methods.
Table I. Effect of A20 Expression on TNF-induced Expression 
of IL-6 and GM-CSF in L929sA Transfectants
IL-6 GM-CSF
2mTNF 1mTNF 2mTNF 1mTNF
pg/ml pg/ml
L929SA-NEO ,5 6561 ,14 691
,5 6150 ,14 760
L929SA-GFP ,5 2187 ,14 810
,5 2560 ,14 840
L929SA-GFP/A20 ,5 15 ,14 92
,5 45 ,14 115
Cells were stimulated for 6 h with 1,000 IU/ml mTNF and supernatants were tested
for the presence of IL-6 and GM-CSF as described in Materials and Methods. Results
are shown for two representative subclones (total analyzed, 5).
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by Tax (Fig. 4 A). These results further indicate that A20
interferes with TNF-induced NF-kB–dependent gene ex-
pression at the level of an RIP- or TRAF2-initiated NF-kB
transactivation pathway that is independent of NIK.
To further substantiate this hypothesis, we also analyzed
the effect of A20 on the activation of NF-kB by a number
of other stimuli for which NF-kB activation has been
shown to be mediated by TRAF2 or TRAF family mem-
bers. IL-1 engages TRAF6 in its signaling pathway (Cao et
al., 1996), whereas CD40 initiates NF-kB activation via
TRAF2, TRAF5, and TRAF6 (Hu et al, 1994; Ishida et al.,
1996a,b). Overexpression of A20 completely prevented
IL-1–induced NF-kB activation in 293T cells (Fig. 4 B),
which confirms previously published data (Jäättelä et al.,
1996). Similarly, NF-kB activation induced by overexpres-
sion of CD40 was also abolished when A20 was coex-
pressed (Fig. 4 C). These results are in agreement with the
above suggested role for a TRAF-initiated signaling path-
way as target for A20.
Surprisingly, A20 also inhibited NF-kB activation by the
protein kinase C activator TPA (Fig. 5). The latter also ac-
tivates AP1- and SRE-dependent gene expression in 293T
cells. Therefore, we analyzed whether A20 could also pre-
vent the TPA-induced expression of a luciferase reporter
gene whose expression is controlled by AP1- or SRE-bind-
ing proteins. However, in contrast to NF-kB–dependent
gene expression, the TPA-induced activation of AP1- or
SRE-dependent transcription was not sensitive to A20.
These results demonstrate that A20 can also act as a spe-
cific inhibitor of NF-kB–dependent gene expression in-
duced by TPA. It remains to be seen whether TRAFs or
downstream signaling proteins are also involved in NF-kB
activation by this stimulus.
A20 Does Not Prevent the TNF-induced Activation of 
p38 MAP Kinase
Recently, we and others demonstrated an important role
for TNF-induced activation of p38 MAP kinase in the
transactivation of NF-kB (Beyaert et al., 1996; Bergmann
et al., 1998; Vanden Berghe et al., 1998). Moreover, TNF-
induced p38 MAP kinase activation was shown to be me-
diated by TRAF2 (Carpentier et al., 1998). To investigate
whether A20 inhibited the TNF-induced transactivation of
NF-kB by preventing p38 MAP kinase activation, we
analyzed the TNF-induced activation of p38 MAP kinase
in GFP/A20–transfected versus GFP-transfected L929SA
cells. p38 MAP kinase activation was revealed by immuno-
detection of phosphorylated p38 MAP kinase with p38
MAP kinase phosphospecific antibodies. TNF induced a
Figure 2. Subcellular local-
ization of GFP and the fusion
protein GFP/A20. Cells were
seeded in coverglass cham-
bers (Nunc) and GFP fluores-
cence was analyzed by excita-
tion at 490 nm and emission
between 510 and 525 nm
using confocal microscopy
(Zeiss). Transmission (A and
B) and corresponding fluo-
rescence images (C and D)
are shown for the cell lines
L929SA-GFP (A and C) and
L929SA-GFP/A20 (B and
D). No fluorescence was ob-
served in L929SA-neo cells
(data not shown).
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transient phosphorylation of p38 MAP kinase in L929SA-
GFP as well as in L929SA-GFP/A20 cells (Fig. 6). Time ki-
netics of TNF-induced p38 MAP kinase phosphorylation/
activation were similar in both cell lines, although in some
experiments dephosphorylation occurred slightly faster in
A20-expressing cells. These results make it unlikely that
A20 prevents NF-kB transactivation by inhibiting the
TNF-induced activation of p38 MAP kinase.
NF-kB Activation Cannot Be Rescued from A20 
Inhibition by CBP/p300 Overexpression
CREB-binding protein (CBP) and p300 are coactivators
that link transcriptional activators to the basal transcrip-
tional apparatus. Both CBP and p300 were shown to act as
coactivators of NF-kB–dependent gene expression by a di-
rect interaction with the p65 subunit (Gerritsen et al.,
1997; Perkins et al., 1997). The latter interaction was re-
cently shown to be enhanced by phosphorylation of p65 by
protein kinase A (Zhong et al., 1998). To analyze whether
A20 would prevent NF-kB transactivation by affecting the
interaction between p65 and CBP/p300, we analyzed if
TNF-induced NF-kB–dependent reporter gene expression
could be rescued from A20 inhibition by overexpression of
p300 in 293T cells. Basal and TNF-induced NF-kB activity
was increased approximately threefold when p300 was co-
expressed (Fig. 7), which is in agreement with a coactiva-
tor function for p300. However, p300 could not rescue
TNF-induced NF-kB activation from inhibition by A20.
These results make it unlikely that A20 prevents TNF-
induced NF-kB–dependent gene expression by abolishing
the transactivation of NF-kB by CBP/p300.
A20 Binds to a Novel NF-kB Inhibitory Protein ABIN
Although it is known that the NF-kB inhibiting potential
of A20 resides in its COOH-terminal zinc finger–contain-
ing domain (Song et al., 1996; Natoli et al., 1998; Heyninck
et al., 1999), the underlying mechanism is still unclear.
Therefore, we used the yeast two-hybrid system to screen
an L929r2 cDNA library for A20 interacting proteins that
might be involved in the negative regulation of NF-kB.
From 1.3 3 106 transformants, 10 clones expressed A20-
interacting proteins, including A20 itself (De Valck et al.,
1996) and 14-3-3 proteins (De Valck et al., 1997). Three
clones contained COOH-terminal fragments of the same
cDNA encoding a protein that we named ABIN. Full-
length ABIN cDNA was subsequently isolated from the
L929r2 cDNA library by colony hybridization with a frag-
ment cloned by two-hybrid analysis as a probe. Several
cDNAs were isolated and in the longest cDNA stop co-
Figure 3. Effect of A20 on NF-kB activation induced by TNF or
overexpression of TRADD, RIP, TRAF2, and NIK in 293T cells.
Cells were transfected with 1 mg plasmid DNA consisting of 300
ng empty plasmid or plasmids encoding TRADD, RIP, TRAF2,
or NIK, 100 ng pUT651, 100 ng pNFconluc, 200 ng pCAGGS-
GFP, or pCAGGS-GFP/A20, as well as 300 ng carrier plasmid
DNA. Cells not expressing the NF-kB inducing proteins were left
untreated or were treated for 6 h with 1,000 IU/ml hTNF. All
cells were lysed 24 h after transfection and luciferase and b-galac-
tosidase activities were measured. Promoter activity is expressed
as the luciferase (luc) activity relative to the b-galactosidase (gal)
activity. Data from a representative experiment (total number of
experiments, 3) are expressed as the mean value (n 5 3) with
SD , 10%.
Figure 4. Effect of A20 on NF-kB activation by HTLV-1 Tax
(A), IL-1 (B), or CD40 (C) in 293T cells. Cells were transfected
with reporter gene constructs and GFP/A20 as described in the
legend of Fig. 3. In A, NF-kB activation was induced by stimula-
tion with 1,000 IU/ml hTNF for 6 h or by coexpression of an ex-
pression plasmid for HTLV-1 Tax (pIEX). In B, NF-kB activa-
tion was induced by stimulation with 7,000 IU/ml IL-1b for 6 h,
whereas in C NF-kB activation was induced by coexpression of
an expression plasmid for CD40 (pCDNA3-CD40). All cells
were lysed 24 h after transfection and analyzed for luciferase ex-
pression as described in Materials and Methods. Data from a rep-
resentative experiment (total number of experiments, 3) are ex-
pressed as the mean (n 5 3) with SD , 10%.
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dons were identified in all three frames 59 of a potential
initiator methionine. Two different splice variants were
found of z2,800 and 2,600-nt long. Northern blot analysis
revealed that ABIN is expressed in all murine tissues
tested as an mRNA of z2,800 bp that is in accordance
with the length of the cloned full-length cDNA (data not
shown). In contrast to A20, ABIN mRNA is constitutively
expressed in both TNF-sensitive and TNF-resistant sub-
clones derived from the parental cell line L929s (Van-
haesebroeck et al., 1991), irrespective of TNF stimulation.
The two splice variants of the ABIN cDNA contained
an open reading frame of 1,941 and 1,782 nucleotides re-
spectively, initiating at two different methionines [ABIN
(1-647) and ABIN (54-647)] (GenBank/EMBL/DDBJ ac-
cession numbers AJ242777 and AJ242778). These cDNAs
encode proteins of 72 and 68 kD, containing an am-
phiphatic helix with four consecutive repeats of a leucine
followed by six random amino acid residues, which is
characteristic of a leucine zipper structure. Also, full-
length ABIN(1-647) and ABIN(54-647) bound A20 in a
yeast two-hybrid assay, confirming the original interaction
found with the 39 COOH-terminal fragments ABIN(390-
599), ABIN(249-647), and ABIN(312-647). The latter all
contain the putative leucine zipper protein interaction mo-
tif (397-420). In addition, ABIN also interacted with A20
in mammalian cells since ABIN was able to coimmunopre-
cipitate with A20 in 293T cells that were transiently trans-
fected with an expression plasmid for chimeric GFP-A20
protein and ABIN with an NH2-terminal E-tag (Fig. 8).
Interestingly, interaction of ABIN with A20 required
the COOH-terminal, zinc finger–containing part of A20
[A20(369-775)]. This domain was shown previously to be
required for dimerization of A20 and for the interaction of
A20 with 14-3-3 proteins (De Valck et al., 1996, 1997).
Furthermore, overexpression of this domain is sufficient
for the NF-kB inhibiting effects (Song et al., 1996; Natoli
Figure 5. Effect of A20 on TPA-induced activation of gene ex-
pression mediated by NF-kB, AP1, or SRE. 293T cells were
transfected with 100 ng pUT651 and 100 ng NFconluc, pAP1-luc,
or pSRE-luc, in combination with 100 ng pCAGGS-GFP or
pCAGGS-GFP/A20. Cells were either left untreated or treated
with 200 ng/ml TPA for 6 h. Cells were analyzed for luciferase ex-
pression as described in Materials and Methods. Data from a rep-
resentative experiment (total number of experiments, 2) are ex-
pressed as the mean (n 5 3) with SD , 10%.
Figure 6. A20 has no effect on TNF-induced p38 MAP kinase ac-
tivation. L929sA-GFP and L929sA-GFP/A20 cells were left un-
treated or treated with 1,000 IU/ml mTNF during 5, 15, or 30 min
and immediately lysed in SDS lysis buffer. Total lysates were sep-
arated on SDS-PAGE and activated p38 MAP kinase was de-
tected by Western blotting using polyclonal antibodies recogniz-
ing specifically phosphorylated p38 MAP kinase. As a control for
the amount of protein loaded, total expression of p38 MAP ki-
nase was revealed with polyclonal anti-p38 MAP kinase antibod-
ies and found to be identical in all samples (data not shown).
Figure 7. Effect of overexpression of p300 on TNF-induced NF-
kB activation and its inhibition by A20. 293T cells were trans-
fected with 100 ng pUT651 and 100 ng pNFconluc in combination
with or without 100 ng pCMV-p300. 100 ng pCAGGS-GFP,
pCAGGS-GFP/A20, or empty vector pCAGGS were cotrans-
fected as indicated. 24 h after transfection, cells were either left
untreated or treated with 1,000 IU/ml hTNF for 6 h. All cells
were lysed and analyzed for luciferase expression as described in
Materials and Methods. Data from a representative experiment
(total number of experiments, 3) are expressed as the mean (n 5
3) with SD , 10%.
Figure 8. Coimmunoprecipitation of A20 and ABIN after tran-
sient transfection of the encoding plasmids of E-tagged ABIN
and GFP, GFP-A20, GFP-A20(369-775), GFP-A20(1-368), or an
empty expression vector as a negative control in 293T cells. Im-
munoprecipitation (top) was performed with anti-GFP antibody
and Western blot detection with anti—E-tag antibody. To control
expression levels of ABIN, 10 ml of lysates was subjected to SDS-
PAGE and Western blot detection with anti—E-tag antibody
(bottom).
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et al., 1998; Heyninck et al., 1999). In contrast, the NH2-
terminal part of A20 has been shown to interact with
TRAF2 (Song et al., 1996), suggesting that A20 acts as an
adapter protein between TRAF2 and ABIN. The interac-
tion between A20 and ABIN was not influenced by stimu-
lation with TNF (data not shown). To characterize the
subcellular distribution of ABIN, we transiently trans-
fected GFP-A20 and E-tagged ABIN cDNA in 293T cells
and analyzed their expression by means of GFP fluo-
rescence and immunofluorescence via the anti–E-tag
antibody, respectively. ABIN colocalized with A20 through-
out the cytoplasm, both in unstimulated and in TNF-stim-
ulated cells (data not shown).
Database similarity searches (BLAST) showed that ABIN
is the murine homologue of the human cDNA encoding
a human immunodeficiency virus (HIV) Nef–associating
factor, NAF1 (Fukushi et al., 1999). HIV–Nef contributes
substantially to disease pathogenesis by augmenting virus
replication and markedly perturbing T cell function. Inter-
estingly, the effect of Nef on host cell activation has been
explained in part by its interaction with specific cellular
proteins involved in signal transduction (for review see
Harris, 1996), of which ABIN might be an example.
ABIN Mimics the NF-kB Inhibiting Effects of A20
Since both A20 and Nef were shown previously to block
the signal transduction pathway leading to NF-kB activa-
tion upon stimulation with TNF or IL-1 and T cell recep-
tor stimulation, respectively (Niederman et al., 1992; Ban-
dres et al., 1994; Jäättelä et al., 1996; Song et al., 1996), we
investigated the effect of ABIN on NF-kB–dependent re-
porter gene expression in transiently transfected 293T
cells. GFP and GFP-A20 served as negative and positive
controls, respectively. Similar to A20, both splice variants
of ABIN were able to block TNF-induced NF-kB activa-
tion in these cells, with the shorter NH2-terminal truncated
isoform being slightly more effective (Fig. 9 A). Overex-
pression of a combination of suboptimal doses of A20 and
ABIN, on their own not sufficient to inhibit NF-kB activa-
tion, diminished NF-kB activation upon stimulation with
TNF considerably (Fig. 9 B). This suggests that ABIN
might mediate the NF-kB inhibiting effect of A20. Fur-
thermore, cotransfection of expression plasmids encoding
the TNF receptor–associated signaling proteins TRADD,
RIP, TRAF2, and NIK together with the expression plas-
mid encoding ABIN, showed that the latter completely in-
hibited NF-kB activation induced by TRADD or RIP, and
partially TRAF2-induced NF-kB activation. In contrast,
no effect of ABIN was observed when NF-kB–dependent
reporter gene expression was induced by NIK or more di-
rectly by overexpression of the p65 subunit of NF-kB (Fig.
9 C). Similarly, Tax-induced NF-kB activation that is
TRAF-independent and is insensitive to A20, was also not
affected by coexpression of ABIN (Fig. 9 D). These results
suggest that ABIN, like A20, inhibits TNF-induced NF-kB
Figure 9. (A) Effect of two splice variants of ABIN [ABIN(1-647) and ABIN(54-647)] on the activation of NF-kB, measured by re-
porter gene activity. 293T cells were transiently transfected with 100 ng pUT651, 100 ng pNFconluc, and 200 ng expression plasmid and
stimulated with TNF (1,000 IU/ml) during 6 h. As a control, plasmids encoding GFP and GFP-A20 were transfected. (B) Effect of tran-
sient transfection of suboptimal quantities of expression plasmids encoding A20 (5 ng) and ABIN (20 ng) on TNF-mediated NF-kB in-
duction in 293T cells. (C) Effect of ABIN on NF-kB activation in 293T cells induced by overexpression of TRADD, RIP, TRAF2, NIK,
or p65 after transfection of 300 ng of their encoding plasmids, together with 100 ng pUT651, 100 ng pNFconluc, and 500 ng pCAGGS-
ABIN. (D) Effect of ABIN on NF-kB activation induced by overexpression of Tax in 293T cells. Cells were transfected with 1 mg plas-
mid DNA consisting of 300 ng empty plasmid or plasmid encoding Tax (pIEX), 100 ng pUT651, 100 ng pNFconluc, 200 ng pCAGGS or
pCAGGS-ABIN, and 300 ng carrier plasmid DNA. All cells were lysed 30 h after transfection. In all experiments, cell extracts were an-
alyzed for luciferase and b-galactosidase activity and the data are plotted as luc/gal, which is representative of NF-kB activity. Each
value is the mean (n 5 3) with SD , 10%.
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activation at the level of RIP or TRAF2 proteins, preced-
ing the activation of the NIK–IkB kinase steps.
Discussion
The zinc finger protein A20 is encoded by an immediate
early response gene and acts as an inhibitor of NF-kB–
dependent gene expression induced by different stimuli in-
cluding TNF and IL-1 (Cooper et al., 1996; Jäättelä et al.,
1996; Song et al., 1996). Here we show that the TNF-
induced expression of GM-CSF and IL-6, as well as the
TNF-induced expression of a luciferase reporter gene that
is expressed under control of the complete hIL-6 promoter
or the minimal hIL-6 promoter preceded by 3 NF-kB rec-
ognition sequences, are clearly inhibited in L929sA cells
stably transfected with A20. These results are consistent
with the fact that NF-kB is required for IL-6 and GM-CSF
gene transcription (Schreck et al., 1990; Zhang et al.,
1990). Surprisingly, gel retardation assays revealed that
overexpression of A20 had no effect on the TNF-induced
nuclear translocation and DNA binding of NF-kB. Also
the constitution of the NF-kB complex was not altered in
cells overexpressing A20, and consisted in both cases of a
p65 and a p50 subunit as revealed by gel supershift assays
(data not shown). Therefore, the inhibition of NF-kB–
dependent gene expression by A20 cannot be explained by
an A20-induced alteration in the subunits of NF-kB. Fer-
ran et al. (1998) showed recently that A20 acts upstream of
IkB degradation and prevented the nuclear translocation
of NF-kB. The reason for the discrepancy with our results
is still unclear. Because activation of NF-kB is an early re-
sponse after stimulation with TNF, we analyzed NF-kB
translocation at 5, 15, and 30 min after TNF stimulation,
whereas results of Ferran et al. were obtained 2 h after
TNF stimulation. The latter is quite late and might already
be regulated by secondary factors that are A20-sensitive.
Moreover, NF-kB activation at later times is also regu-
lated by TNF-induced negative regulatory proteins such as
IkBa and A20 whose expression is itself under the control
of NF-kB, further raising the complexity of NF-kB activa-
tion at later time points (Krikos et al., 1992; LeBail et al.,
1993). Alternatively, we cannot exclude cell type–depen-
dent differences.
Until now, the mechanism by which A20 blocks the ac-
tivation of NF-kB–dependent gene regulation was not
known. Up to now, the NIK–IkB kinase pathway has been
assumed to be responsible for NF-kB activation upon TNF
treatment. However, our finding that A20 has no effect on
the translocation of NF-kB to the nucleus argues against
this pathway as the target for A20. Moreover we demon-
strated that A20 could inhibit RIP- and TRAF2- but not
NIK-induced NF-kB–dependent reporter gene activation,
suggesting that A20 interferes with NF-kB activation up-
stream of NIK. These conclusions were confirmed by the
inability of A20 to block Tax-induced NF-kB activation
since the latter was shown to activate NF-kB by directly
interfering with the downstream kinases NIK, IKKa, and
IKKb, independent of TRAF2 (Chu et al., 1998; Uhlik et
al., 1998; Yin et al., 1998). 
The above results suggest that TNF-induced NF-kB–
dependent gene activation requires at least two different
pathways: an NIK-mediated pathway leading to transloca-
tion of NF-kB to the nucleus, and an NIK-independent
pathway leading to transactivation of NF-kB. Our results
demonstrate that A20 specifically interferes with the NF-
kB transactivation pathway. A20 has also been shown to
interact with the TNF receptor–associated protein TRAF2
(Song et al., 1996). Interestingly, TRAF2 as well as some
other members of the TRAF protein family, including
TRAF5 and TRAF6, were shown to play a positive role in
NF-kB activation induced by different cytokines, such as
TNF, IL-1, and CD40 ligand, via their interaction with the
NF-kB inducing kinase NIK (Cao et al., 1996; Malinin
et al., 1997). The fact that A20 directly associates with
TRAF2, as well as our observation that A20 not only pre-
vents NF-kB activation by TNF but also by IL-1 and CD40
overexpression, points to a role of a TRAF-mediated sig-
naling pathway as a target for A20. However, gene knock-
out studies have recently shown that TRAF2 is not ab-
solutely required for NF-kB activation by TNF, although
this probably is a consequence of redundancy within the
TRAF protein family (Yeh et al., 1997). Alternatively,
RIP may be more important than TRAF2 in mediating ac-
tivation of NF-kB upon TNF stimulation (Kelliher et al.,
1998).
The nature of the RIP/TRAF–initiated NF-kB transacti-
vation signal is still unclear. Recently, an important role in
the transactivating potential of NF-kB upon TNF stimula-
tion was demonstrated for p38 MAP kinase (Beyaert et
al., 1996; Bergmann et al., 1998; Vanden Berghe et al.,
1998). This kinase becomes activated by stimulation of
cells with TNF as well as by overexpression of TRAF2. In
contrast, overexpression of NIK did not induce the phos-
phorylation of p38 MAP kinase, indicating that a separate
pathway initiating at TRAF2 leads to the activation of p38
MAP kinase (Carpentier et al., 1998). Similar to the effect
of A20 overexpression, inhibition of p38 MAP kinase with
the specific inhibitor SB203580 also prevented NF-kB–
dependent gene expression without altering the transloca-
tion of NF-kB to the nucleus (Beyaert et al., 1996; Berg-
mann et al., 1998). As these results suggested that A20
might interfere with the TRAF2-p38 MAP kinase path-
way, we investigated if A20 was able to prevent the TNF-
induced activation of p38 MAP kinase. However, no
significant effect of A20 on p38 MAP kinase phosphory-
lation, which is a marker for its activation, could be ob-
served. Although these results indicate that A20 does not
act upstream of p38 MAP kinase activation, it is still possi-
ble that A20 interferes with the TRAF2-p38 MAP kinase/
NF-kB transactivation pathway downstream of p38 MAP
kinase. The validation of this possibility awaits the identifi-
cation of the p38 MAP kinase substrate that is involved in
NF-kB transactivation. Alternatively, our results might
also fit with the existence of another RIP- or TRAF2-initi-
ated pathway that contributes to NF-kB–dependent tran-
scription, and which is blocked by A20.
Our observation that A20 also prevents NF-kB activa-
tion by TPA indicates that the A20-sensitive pathway
might also be activated by protein kinase C, at least in
some cell lines. Similar results were obtained by Cooper et
al. (1996). In contrast, stable expression of A20 has been
reported to be unable to prevent TPA-induced NF-kB ac-
tivation in breast carcinoma MCF cells (Jäättelä et al.,
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1996). These controversial results might reflect a cell type
specific effect or differences in A20 expression levels
upon stable and transient transfection. It should be men-
tioned that a role for protein kinase C in TNF-induced
NF-kB transactivation has been suggested recently based
on the inhibition with a protein kinase C inhibitor (Berg-
mann et al., 1998). Whether protein kinase C functions
downstream of TRAF2 or in a totally separate pathway re-
mains to be established. In any case, the protein kinase
C–mediated pathway sensitive to A20 seems to regulate
specifically NF-kB–dependent gene expression, as TPA-
induced transcription that is controlled by an AP1-respon-
sive element or a SRE was not sensitive to A20. The latter
result, as well as our finding that Tax-mediated NF-kB ac-
tivation is not affected by A20, also excludes an aspecific
effect of A20 on the general transcription machinery.
The transcription activating potential of NF-kB has
been primarily attributed to the p65 subunit, whose trans-
activating potential resides in its COOH-terminal portion
(Ballard et al., 1992; Schmitz et al., 1994). Furthermore,
the p65 subunit becomes phosphorylated during the acti-
vation of NF-kB upon TNF stimulation (Naumann and
Scheidereit, 1994; Schmitz et al., 1995). Indeed, a p65
phosphorylating activity was found in the IkB kinase com-
plex (Mercurio et al., 1997). Moreover, it was also shown
that IkB is associated with the protein kinase A catalytic
subunit that can phosphorylate the p65 in its rel homology
domain resulting in enhanced activity of NF-kB (Zhong et
al., 1997). Recently, p65 phosphorylation was shown to
promote an interaction between p65 and the coactivators
CBP/p300 (Zhong et al., 1998). The latter were previously
shown to synergistically enhance the transcription activat-
ing potential of NF-kB (Gerritsen et al., 1997; Perkins et
al., 1997). However, it is unlikely that A20 interferes with
protein kinase A or another signaling pathway leading to
the engagement of the coactivators CBP/p300 in the trans-
activation of NF-kB because we were unable to rescue
NF-kB activation from A20 inhibition by overexpression
of CBP/p300. Moreover, activation of the protein kinase A
catalytic subunit requires degradation of IkB and the acti-
vation of the NIK–IkB kinase pathway which is, however,
not modulated by A20. Also, A20 did not interfere with
NF-kB–dependent gene expression obtained by overex-
pression of the p65 subunit as such (Cooper et al., 1996).
In endothelial cells, TRAF2 has been recently shown to
translocate to the nucleus, where it might directly regulate
transcription (Min et al., 1998). Because A20 can bind
to TRAF2 (Song et al., 1996), and exclusively resides in
the cytosol, A20 might prevent nuclear localization of
TRAF2.
Screening of a cDNA library for A20 interacting pro-
teins by the yeast two-hybrid system has revealed some
isoforms of the 14-3-3 proteins that interact with the
COOH-terminal zinc finger domain of A20 (Vincenz and
Dixit, 1996; De Valck et al., 1997). 14-3-3 proteins were
shown to function as adapter proteins between A20 and
c-Raf. Moreover, 14-3-3 also functioned as a chaperone in
these studies (Vincenz and Dixit, 1996). However, by mu-
tation analysis we previously demonstrated that the inter-
action of 14-3-3 proteins with A20 is not involved in the ef-
fect of A20 on NF-kB activation (De Valck et al., 1997).
By the yeast two-hybrid screening system, we also identi-
fied ABIN as a novel A20-interacting leucine zipper pro-
tein. The interaction of ABIN with A20 was confirmed in
human cells and shown to map to the functional COOH-
terminal zinc finger–containing domain of A20. Upon
overexpression, ABIN potently inhibits NF-kB activa-
tion induced by TNF. Furthermore, also ABIN interferes
with TNF-induced NF-kB activation at the level of RIP/
TRAF2. Therefore, the ability of A20 to block TNF-medi-
ated NF-kB activation is likely to involve the binding of
the NF-kB inhibitory protein ABIN to the COOH-termi-
nal zinc finger domain of A20. Moreover, the fact that A20
can also interact via its NH2-terminal domain with TRAF1
and TRAF2 (Song et al., 1996) suggests that A20 can re-
cruit ABIN to the TRAF2 complex in the TNF signaling
pathway.
In conclusion, A20 appears to prevent NF-kB–depen-
dent gene expression by specifically interfering in the cy-
tosol with a novel RIP/TRAF2–initiated transactivation
pathway, thus inhibiting the TNF-induced expression of
several cytokines and proinflammatory proteins. Since
A20 also inhibits NF-kB activation by IL-1 and CD40,
which all signal to NF-kB activation via members of
the TRAF family, further identification of TRAF-medi-
ated NF-kB transactivation signals may provide means of
achieving more specific antiinflammatory treatments.
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